Drugs in context · 2026
Optimizing care and quality indicators in the management of patients with acute ischaemic heart disease and atherothrombotic stroke: measuring to improve.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
González-Juanatey José R, Vázquez-García Rafael, Campuzano Raquel, Zamorano José Luis, Egocheaga María Isabel, Pascual Fuster Vicente, Martín Sanz Ana, Pedragosa Vall Angels, Masjuan Jaime
Аннотация
BACKGROUND: Acute ischaemic heart disease (AIHD) and atherothrombotic stroke are amongst the leading causes of mortality and disability worldwide, sharing pathogenic mechanisms. Quality indicators (QIs) are essential tools for evaluating and optimizing clinical management. The aim of this article is to develop an integrated organizational model for the care of AIHD and atherothrombotic stroke, incorporating validated and measurable QIs to improve patient outcomes and care coordination.
METHODS: A multidisciplinary panel of cardiologists, neurologists, internists, primary care physicians and nursing staff reached a consensus through structured meetings. After reviewing the literature and scientific recommendations, the most relevant QIs were selected. When clear standards were lacking, the panel established criteria by consensus. The selected QIs were integrated into a care pathway covering the pre-hospital phase through long-term follow-up.
RESULTS: Sixteen key QIs were identified for each process, covering intervention times, secondary prevention, patient satisfaction, rehabilitation, follow-up and clinical outcomes. The model highlights the importance of rapid diagnosis, timely interventions and coordinated discharge planning. Early initiation of intensive lipid-lowering therapy and systematic monitoring of targets such as LDL-c and mortality are emphasized.
CONCLUSION: The proposed QIs and organizational model can be valuable tools for optimizing care and coordination for patients with AIHD and atherothrombotic stroke. They enable the monitoring and improvement of critical aspects of the care process.
METHODS: A multidisciplinary panel of cardiologists, neurologists, internists, primary care physicians and nursing staff reached a consensus through structured meetings. After reviewing the literature and scientific recommendations, the most relevant QIs were selected. When clear standards were lacking, the panel established criteria by consensus. The selected QIs were integrated into a care pathway covering the pre-hospital phase through long-term follow-up.
RESULTS: Sixteen key QIs were identified for each process, covering intervention times, secondary prevention, patient satisfaction, rehabilitation, follow-up and clinical outcomes. The model highlights the importance of rapid diagnosis, timely interventions and coordinated discharge planning. Early initiation of intensive lipid-lowering therapy and systematic monitoring of targets such as LDL-c and mortality are emphasized.
CONCLUSION: The proposed QIs and organizational model can be valuable tools for optimizing care and coordination for patients with AIHD and atherothrombotic stroke. They enable the monitoring and improvement of critical aspects of the care process.